Table 1 –
Definition of the PRECISE criteria [13] as well as a count of scores each MRI interval received in our cohort.
PRECISE criteria | Definition | Intervals, N | Progression to ≥ GG2, N (%) | Progression to ≥ GG3, N (%) |
---|---|---|---|---|
| ||||
1 | Resolution of features (no visible lesions) | 61 | 7 (11.5) | 5 (8.2) |
2 | Reduction in size/conspicuity of lesions | 173 | 30 (17.3) | 15 (8.7) |
3 | Stable MRI appearance; no new lesions | 119 | 21 (17.6) | 10 (8.4) |
4 | Increase in size/conspicuity of lesions | 251 | 59 (23.5) | 55 (21.9) |
5 | Definitive radiologic stage progression | 17 | 5 (29.4) | 3 (17.6) |
Total | 621 | 122 (19.6) | 88 (14.2) |
GG = Gleason grade group; MRI = magnetic resonance imaging; PRECISE = Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation.